Collectively, our data revealed several modes of BMP-pathway inhibition in HL, including overexpression of FSTL3 and downregulation of SMAD2 via genomic alterations, and inhibition of BMPs via overexpressing ETV3. The gene discussed is ETV3; the disease is Hodgkins lymphoma.